What's new

Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 4, Status: Authorised

Jun 2, 2025 - 13:40
 0
Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 4, Status: Authorised
Read More

Tags:

Previous Article

Draft guideline on good pharmacovigilance practices (GVP): Module XVI Addendum I...

Next Article

In changing times, young Germans gun for defence sector jobs

Related Posts

Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Date of authorisation: 12/09/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 26, 2025  0

Human medicines European public assessment report (EPAR): Atazanavir Krka, atazanavir, Date of authorisation: 25/03/2019, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 3, 2025  0

Human medicines European public assessment report (EPAR): Clopidogrel Krka d.d. (previously Zopya), clopidogrel, Date of authorisation: 20/09/2009, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0